Acute liver failure (ALF), an often fatal condition characterized by massive hepatocyte necrosis, is frequently caused by drug poisoning, particularly with acetaminophen (N-acetyl-p-aminophenol/APAP). Hepatocyte necrosis is consecutive to glutathione (GSH) depletion and mitochondrial damage caused by reactive oxygen species (ROS) overproduction. Magnolol, one major phenolic constituent of Magnolia officinalis, have been known to exhibit potent antioxidative activity. In this study, the anti-hepatotoxic activity of magnolol on APAP-induced toxicity in the Sprague-Dawley rat liver was examined. After evaluating the changes of several biochemical parameters in serum, the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH) were elevated by APAP (500 mg/kg) intraperitoneal administration (8 and 24 h) and reduced by treatment with magnolol (0.5 h after APAP administration; 0.01, 0.1, and 1 μg/kg). Histological changes around the hepatic central vein, lipid peroxidation (thiobarbituric acid-reactive substance/TBARS), and GSH depletion in liver tissue induced by APAP were also recovered by magnolol treatment. The data show that oxidative stress followed by lipid peroxidation may play a very important role in the pathogenesis of APAP-induced hepatic injury; treatment with lipid-soluble antioxidant, magnolol, exerts anti-hepatotoxic activity. Our study points out the potential interest of magnolol in the treatment of toxic ALF.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Atkuri, K. R., Mantovani, J. J., Herzenberg, L. A., and Herzenberg, L. A., N-Acetylcysteine-α safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol, 7, 355–359 (2007).
Banerjee, A., Linscheer, W. G., Chiji, H., Murthy, U. K., Cho, C., Nandi, J., and Chan, S. H., Induction of an ATPase inhibitor protein by propylthiouracil and protection against paracetamol (acetaminophen) hepatotoxicity in the rat. Br J Pharmacol, 124, 1041–1047 (1998).
Bedda, S., Laurent, A., Conti, F., Chereau, C., Tran, A., Tran-Van Nhieu, J., Jaffray, P., Soubrane, O., Goulvestre, C., Calmus, Y., Weill, B., and Batteux, F., Mangafodipir prevents liver injury induced by acetaminophen in the mouse. J Hepatol, 39, 765–772 (2003).
Chang, C. P., Hsu, Y. C., and Lin, M. T., Magnolol protects against cerebral ischaemic injury of rat heatstroke. Clin Exp Pharmacol Physiol, 30, 387–392 (2003).
Chang, W. S., Chang, Y. H., Lu, F. J., and Chiang, H. C., Inhibitory effects of phenolics on xanthine oxidase. Anticancer Res, 14, 501–506 (1994).
Chen, S. C., Chang, Y. L., Wang, D. L., and Cheng, J. J., Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells. Br J Pharmacol, 148, 226–232 (2006a).
Chen, Y. H., Lin, S. J., Chen, J. W., Ku, H. H., and Chen, Y. L., Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Br J Pharmacol, 135, 37–47 (2002).
Chen, Y. H., Lin, S. J., Chen, Y. L., Liu, P. L., and Chen, J. W., Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules. Cardiovasc Hematol Disord Drug Targets, 6, 279–304 (2006b).
Chen, Y. L., Lin, K. F., Shiao, M. S., Chen, Y. T., Hong, C. Y., and Lin, S. J., Magnolol, a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits. Basic Res Cardiol, 96, 353–363 (2001).
Chiu, J. H., Wang, J. C., Lui, W. Y., Wu, C. W., and Hong, C. Y., Effect of magnolol on in vitro mitochondrial lipid peroxidation and isolated cold-preserved warm-reperfused rat livers. J Surg Res, 82, 11–16 (1999).
Clark, A. M., El-Feraly, F. S., and Li, W. S., Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci, 70, 951–952 (1981).
Davidson, D. G. and Eastham, W. N., Acute liver necrosis following overdose of paracetamol. Br Med J, 2, 497–499 (1966).
Dimova, S., Hoet, P. H., and Nemery, B., Paracetamol (acetaminophen) cytotoxicity in rat type II pneumocytes and alveolar macrophages in vitro. Biochem Pharmacol, 59, 1467–1475 (2000).
Ferret, P. J., Hammoud, R., Tulliez, M., Tran, A., Trebeden, H., Jaffray, P., Malassagne, B., Calmus, Y., Weill, B., and Batteux, F., Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. Hepatology, 33, 1173–1180 (2001).
Flanagan, R. J., The role of acetylcysteine in clinical toxicology. Med Toxicol, 2, 93–104 (1987).
Fujita, S. and Taira, J., Biphenyl compounds are hydroxyl radical scavengers: their effective inhibition for UV-induced mutation in Salmonella typhimurium TA102. Free Radic Biol Med, 17, 273–277 (1994).
Hamasaki, Y., Kobayashi, I., Zaitu, M., Tsuji, K., Kita, M., Hayasaki, R., Muro, E., Yamamoto, S., Matsuo, M., Ichimaru, T., and Miyazaki, S. Magnolol inhibits leukotriene synthesis in rat basophilic leukemia-2H3 cells. Planta Med, 65, 222–226 (1999).
Homma, M., Oka, K., Kobayashi, H., Niitsuma, T., Yamamoto, S., Itoh, H., and Takahashi, N., Impact of free magnolol excretions in asthmatic patients who responded well to saiboku-to, a Chinese herbal medicine. J Pharm Pharmacol, 45, 844–846 (1993).
Hong, C. Y., Huang, S. S., and Tsai, S. K., Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation. Clin Exp Pharmacol Physiol, 23, 660–664 (1996).
Ikegami, F., Fujii, Y., and Satoh, T. Toxicological considerations of Kampo medicines in clinical use. Toxicology, 198, 221–228 (2004).
Jaw, S. and Jeffery, E. H., Interaction of caffeine with acetaminophen. 1. Correlation of the effect of caffeine on acetaminophen hepatotoxicity and acetaminophen bioactivation following treatment of mice with various cytochrome P450 inducing agents. Biochem Pharmacol, 46, 493–501 (1993).
Jawan, B., Goto, S., Pan, T. L., Lai, C. Y., Luk, H. N., Eng, H. L., Lin, Y. C., Chen, Y. S., Lan, K. M., Hsieh, S. W., Wang, C. C., Cheng, Y. F., and Chen, C. L. The protective mechanism of magnolol, a Chinese herb drug, against warm ischemia-reperfusion injury of rat liver. J Surg Res, 110, 378–382 (2003).
Jones, A. L. Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review. J Toxicol Clin Toxicol, 36, 277–285 (1998).
Knight, T. R., Ho, Y. S., Farhood, A., and Jaeschke, H., Peroxynitrite is a critical mediator of acetaminophen hepatotoxicity in murine livers: protection by glutathione. J Pharmacol Exp Ther, 303, 468–475 (2002).
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., and Wollman, J., Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1, 431–435 (1981).
Kong, C. W., Tsai, K., Chin, J. H., Chan, W. L., and Hong, C. Y., Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Shock, 13, 24–28 (2000).
Lin, Y. R., Chen, H. H., Ko, C. H., and Chan, M. H., Neuroprotective activity of honokiol and magnolol in cerebellar granule cell damage. Eur J Pharmacol, 537, 64–69 (2006).
Lo, Y. C., Teng, C. M., Chen, C. F., Chen, C. C., and Hong, C. Y., Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Biochem Pharmacol, 47, 549–553 (1994).
Moldeus, P., Paracetamol metabolism and toxicity in isolated hepatocytes from rat and mouse. Biochem Pharmacol, 27, 2859–2863 (1978).
Muriel, P., Garciapina, T., Perez-Alvarez, V., and Mourelle, M., Silymarin protects against paracetamol-induced lipid peroxidation and liver damage. J Appl Toxicol, 12, 439–442 (1992).
Ohkawa, H., Ohishi, N., and Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351–358 (1979).
Park, E. J., Zhao, Y. Z., Na, M., Bae, K., Kim, Y. H., Lee, B. H., and Sohn, D. H., Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or D-galactosamine-induced toxicity in rat primary hepatocytes. Planta Med, 69, 33–37 (2003).
Pessayre, D., Wandscheer, J. C., Cobert, B., Level, R., Degott, C., Batt, A. M., Martin, N., and Benhamou, J. P., Additive effects of inducers and fasting on acetaminophen hepatotoxicity. Biochem Pharmacol, 29, 2219–2223 (1980).
Saito, J., Sakai, Y., and Nagase, H., In vitro anti-mutagenic effect of magnolol against direct and indirect mutagens. Mutat Res, 609, 68–73 (2006).
Saito, J., Shibuya, K., and Nagase, H., Anti-clastogenic effect of magnolol on benzo(a)pyrene-induced clastogenicity in mice. Food Chem Toxicol, 46, 694–700 (2008).
Shih, H. C., Wei, Y. H., and Lee, C. H., Magnolol alters the course of endotoxin tolerance and provides early protection against endotoxin challenge following sublethal hemorrhage in rats. Shock, 22, 358–363 (2004).
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., and Rumack, B. H., Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med, 319, 1557–1562 (1988).
Taira, J., Ikemoto, T., Mimura, K., Hagi, A., Murakami, A., and Makino, K., Effective inhibition of hydroxyl radicals by hydroxylated biphenyl compounds. Free Radic Res Commun, 19Suppl 1, S71–77 (1993).
Tan, D. X., Manchester, L. C., Reiter, R. J., Plummer, B. F., Limson, J., Weintraub, S. T., and Qi, W., Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med, 29, 1177–1185 (2000).
Teng, C. M., Yu, S. M., Chen, C. C., Huang, Y. L., and Huang, T. F., EDRF-release and Ca+(+)-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Life Sci, 47, 1153–1161 (1990).
Tse, A. K., Wan, C. K., Zhu, G. Y., Shen, X. L., Cheung, H. Y., Yang, M., and Fong, W. F., Magnolol suppresses NFkappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation. Mol Immunol, 44, 2647–2658 (2007).
Wang, J. P., Hsu, M. F., Raung, S. L., Chen, C. C., Kuo, J. S., and Teng, C. M., Anti-inflammatory and analgesic effects of magnolol. Naunyn Schmiedebergs Arch Pharmacol, 346, 707–712 (1992).
Whitehouse, L. W., Wong, L. T., Paul, C. J., Pakuts, A., and Solomonraj, G., Postabsorption antidotal effects of N-acetylcysteine on acetaminophen-induced hepatotoxicity in the mouse. Can J Physiol Pharmacol, 63, 431–437 (1985).
Wong, S. H., Knight, J. A., Hopfer, S. M., Zaharia, O., Leach, C. N., Jr., and Sunderman, F. W. Jr., Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem, 33, 214–220 (1987).
Yamazaki, R., Sugatani, J., Fujii, I., Kuroyanagi, M., Umehara, K., Ueno, A., Suzuki, Y., and Miwa, M., Development of a novel method for determination of acetyl-CoA:1-alkyl-snglycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors. Inhibition by magnolol and honokiol from Magnoliae cortex. Biochem Pharmacol, 47, 995–1006 (1994).
Youn, Y. K., Lalonde, C., and Demling, R., The role of mediators in the response to thermal injury. World J Surg, 16, 30–36 (1992).
Zwingmann, C. and Bilodeau, M., Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology, 43, 454–463 (2006).
Yen-Yi Ho and Ming-Tsung Lai contributed equally to this work.
About this article
Cite this article
Chen, Y., Lin, F., Liu, P. et al. Antioxidative and hepatoprotective effects of magnolol on acetaminophen-induced liver damage in rats. Arch. Pharm. Res. 32, 221 (2009). https://doi.org/10.1007/s12272-009-1139-8
- Lipid peroxidation